Model organisms have been used in the study of CADM1 function. A conditional knockout mouse line, called Cadm1tm1.2Brd was generated. Male and female animals underwent a standardized phenotypic screen to determine the effects of deletion. Twenty six tests were carried out on homozygous mutant mice and one significant abnormality was observed: males were infertile. Further analysis showed spermatogenesis had arrested in these mice.
^Gomyo H, Arai Y, Tanigami A, Murakami Y, Hattori M, Hosoda F, Arai K, Aikawa Y, Tsuda H, Hirohashi S, Asakawa S, Shimizu N, Soeda E, Sakaki Y, Ohki M (Feb 2000). "A 2-Mb sequence-ready contig map and a novel immunoglobulin superfamily gene IGSF4 in the LOH region of chromosome 11q23.2". Genomics62 (2): 139–46. doi:10.1006/geno.1999.6001. PMID10610705.
Watabe K, Ito A, Koma YI, Kitamura Y (2004). "IGSF4: a new intercellular adhesion molecule that is called by three names, TSLC1, SgIGSF and SynCAM, by virtue of its diverse function.". Histol. Histopathol.18 (4): 1321–9. PMID12973698.
Kuramochi M, Fukuhara H, Nobukuni T et al. (2001). "TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer". Nat. Genet.27 (4): 427–30. doi:10.1038/86934. PMID11279526.
Masuda M, Yageta M, Fukuhara H et al. (2002). "The tumor suppressor protein TSLC1 is involved in cell-cell adhesion". J. Biol. Chem.277 (34): 31014–9. doi:10.1074/jbc.M203620200. PMID12050160.
Fukuhara H, Kuramochi M, Fukami T et al. (2003). "Promoter methylation of TSLC1 and tumor suppression by its gene product in human prostate cancer". Jpn. J. Cancer Res.93 (6): 605–9. PMID12079507.
Allinen M, Peri L, Kujala S et al. (2002). "Analysis of 11q21-24 loss of heterozygosity candidate target genes in breast cancer: indications of TSLC1 promoter hypermethylation". Genes Chromosomes Cancer34 (4): 384–9. doi:10.1002/gcc.10079. PMID12112527.
Yageta M, Kuramochi M, Masuda M et al. (2002). "Direct association of TSLC1 and DAL-1, two distinct tumor suppressor proteins in lung cancer". Cancer Res.62 (18): 5129–33. PMID12234973.
Jansen M, Fukushima N, Rosty C et al. (2003). "Aberrant methylation of the 5' CpG island of TSLC1 is common in pancreatic ductal adenocarcinoma and is first manifest in high-grade PanlNs". Cancer Biol. Ther.1 (3): 293–6. PMID12432281.
Honda T, Tamura G, Waki T et al. (2003). "Hypermethylation of the TSLC1 gene promoter in primary gastric cancers and gastric cancer cell lines". Jpn. J. Cancer Res.93 (8): 857–60. PMID12716461.
Shingai T, Ikeda W, Kakunaga S et al. (2003). "Implications of nectin-like molecule-2/IGSF4/RA175/SgIGSF/TSLC1/SynCAM1 in cell-cell adhesion and transmembrane protein localization in epithelial cells". J. Biol. Chem.278 (37): 35421–7. doi:10.1074/jbc.M305387200. PMID12826663.
Ito A, Okada M, Uchino K et al. (2003). "Expression of the TSLC1 adhesion molecule in pulmonary epithelium and its down-regulation in pulmonary adenocarcinoma other than bronchioloalveolar carcinoma". Lab. Invest.83 (8): 1175–83. doi:10.1097/01.LAB.0000081391.28136.80. PMID12920246.
Fukami T, Fukuhara H, Kuramochi M et al. (2003). "Promoter methylation of the TSLC1 gene in advanced lung tumors and various cancer cell lines". Int. J. Cancer107 (1): 53–9. doi:10.1002/ijc.11348. PMID12925956.
Uchino K, Ito A, Wakayama T et al. (2003). "Clinical implication and prognostic significance of the tumor suppressor TSLC1 gene detected in adenocarcinoma of the lung". Cancer98 (5): 1002–7. doi:10.1002/cncr.11599. PMID12942568.
Fukuhara H, Masuda M, Yageta M et al. (2003). "Association of a lung tumor suppressor TSLC1 with MPP3, a human homologue of Drosophila tumor suppressor Dlg". Oncogene22 (40): 6160–5. doi:10.1038/sj.onc.1206744. PMID13679854.
Ito T, Shimada Y, Hashimoto Y et al. (2003). "Involvement of TSLC1 in progression of esophageal squamous cell carcinoma". Cancer Res.63 (19): 6320–6. PMID14559819.
Mao X, Seidlitz E, Ghosh K et al. (2004). "The cytoplasmic domain is critical to the tumor suppressor activity of TSLC1 in non-small cell lung cancer". Cancer Res.63 (22): 7979–85. PMID14633730.